Champion Health uses physiotherapist review to strengthen digital MSK triage

Physitrack plc

Champion Health is focusing its digital musculoskeletal offering on a simple proposition: employees should receive earlier support, and a registered physiotherapist should review every completed assessment before treatment is assigned.

Work-related musculoskeletal disorders remain a major cause of lost working time in Great Britain. An estimated 7.1 million working days were lost to work-related MSK conditions in 2024/25. The actual organisational cost is higher because recorded absence does not capture reduced productivity from employees who continue working while in pain.

Back, neck, shoulder and wrist problems can also become more expensive when treatment is delayed. An employee with mild symptoms may continue working without knowing which activities to modify or avoid. They may also change how they move to compensate for pain, which can place additional strain on surrounding muscles. If the problem worsens, a manageable issue can develop into a longer absence.

Digital triage is intended to reduce that delay.

Champion Health’s Nexa requires a registered physiotherapist to review every completed assessment before a treatment plan is issued. That means the platform does not rely entirely on automated routing when deciding what support an employee should receive.

Employers should compare MSK-related absence before and after implementation, while also tracking how long employees wait between reporting symptoms and starting treatment. Recurrence rates are also important because repeated cases may indicate that symptoms are being managed without fully addressing the underlying problem. Changes in pain and productivity can help capture the impact of presenteeism, which is otherwise difficult to see in absence records.

Employers can compare lost working days with average daily wage and cover costs, then set the estimated saving against the annual platform fee.

Nexa is designed to get employees assessed earlier, put a physiotherapist into every treatment decision and give employers data they can use to judge whether the service is reducing MSK-related absence and productivity loss.

Physitrack plc (PTRK.ST), together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. 

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Physitrack expands digital physiotherapy offering

Physitrack combines exercise prescription, patient management and AI-assisted documentation in its digital physiotherapy platform.

Physitrack CEO Henrik Molin outlines EMR Launch, AI strategy and 2027 growth plans

Physitrack CEO Henrik Molin discusses 14% year-on-year revenue growth, early sign-ups for its new electronic medical record system, remote therapeutic monitoring and plans to expand its AI-powered healthcare technology offering in 2027.

Physitrack revenue growth accelerates to 14% in Q3 2026

Physitrack reported 14% year-on-year revenue growth to €3.6m in Q3 2026, its strongest quarterly growth of the year. The company recorded its eighth consecutive quarter of positive operating cash flow, while 480 clinics signed up for its new electronic medical record platform ahead of paid subscriptions launching in January 2027.

Physitrack EMR attracts 480 clinics ahead of November launch

Physitrack PLC reports that 480 clinics representing more than 4,800 clinicians have signed up for its AI-powered electronic medical record platform ahead of its wider launch on 2 November 2026.

Irish employers urged to strengthen workplace mental health support

Irish employers are being urged to combine employee assistance programmes with earlier mental health risk assessments to address workplace pressures and support employee wellbeing.

Physitrack to publish Q3 2026 results on 20 October

Physitrack PLC will publish its Q3 2026 interim report on 20 October 2026 at 08:00 CET, followed by a webcast at 18:00 CET featuring CEO Henrik Molin and CFO Matt Poulter. Investors will be able to submit questions through Zoom’s Q&A function.

Search